Jim Simons's position in Regeneron Pharmaceuticals is currently worth $429 Million. That's 0.54% of their equity portfolio (23rd largest holding). The first Regeneron Pharmaceuticals trade was made in Q2 2013. Since then Jim Simons bought shares eighteen more times and sold shares on seventeen occasions. The stake costed the investor $370 Million, netting the investor a gain of 16% so far.